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Abstract
Background: Cardiovascular disease (CVD) is a leading cause of death worldwide, and the number of people at risk is
continuously growing. New methods for early risk prediction are therefore needed to actuate prevention strategies before
the individuals are diagnosed with CVD. Several studies report that aerobic fitness level, measured as maximal oxygen
uptake (VO2max), is the single best predictor of future CVD mortality in healthy people. Based on this, we wanted to study
differences between healthy individuals with a large difference in VO2max-level to identify new biomarkers of low aerobic
fitness that may also have potential as early biomarkers of CVD risk.
Methodology/Principal Findings: Serum samples from 218 healthy individuals with a low VO2max (n = 108, 63 women) or
high VO2max (n = 110, 64 women) were analysed with MR metabolomics. In addition, standard clinical-chemical analyses for
glucose, lipids, liver enzymes, micro-CRP, and colorimetric analysis on circulating choline were performed. Individuals in the
low VO2max-group had increased serum levels of free choline, decreased phosphatidylcholine, increased glucose¸ and
decreased unsaturated fatty acids compared to the individuals in the high VO2max–group.
Conclusions/Significance: Aerobic fitness dependent differences in serum levels of free choline and phosphatidylcholine
are observed. They should be further studied as potential early markers of CVD risk.
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Introduction
Cardiovascular disease (CVD) is a leading cause of death
worldwide, and the number of people at risk is continuously
growing [1]. New methods for early risk prediction are therefore
needed to actuate prevention strategies before the individuals are
diagnosed with CVD. Aerobic fitness level, measured as
maximal oxygen uptake (VO2max), is a strong marker for
cardiac health. Large-scale epidemiological studies have dem-
onstrated that low VO2max is the single best predictor of future
CVD mortality both in healthy individuals and in patients with
CVD [2–6]. Based on this, more knowledge of the differences
between healthy individuals with a large difference in VO2max-
level will be of great interest to identify new biomarkers of low
aerobic fitness that may also have a potential as an early
biomarker of CVD risk.
Emerging metabolite profiling technologies have recently made
it possible to acquire ‘‘snapshots’’ of the metabolic processes at a
given point in time [7,8]. This methodology, termed metabolo-
mics, involves a high throughput analysis of small-molecular
metabolites that are downstream products of preceding gene
expressions and protein activity. Within systems biology, magnetic
resonance (MR) metabolomics has become one of the key
platforms, allowing rapid analysis of samples with minimal sample
preparation. The acquired metabolic profiles can be useful for a
better understanding of the metabolic perturbations associated
with health and disease.
Previously, serum and plasma MR metabolomics have been
successfully used in the detection of biomarkers associated with
various clinical conditions such as coronary artery disease and
myocardial infarction [9–11]. Serum metabolites such as citric
acid, threonine, and choline have previously been associated with
the incidence of CVD, but so far the evidence is sparse [9–11]. To
our knowledge, no previous study has searched for serum
metabolites associated with aerobic fitness level in a healthy
population. The aim of the present study was to investigate
metabolic differences between healthy individuals with high and
low VO2max by MR metabolomics, and further to describe these
differences qualitatively and quantitatively.
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Results
The high and the low VO2max-groups, which were matched for
age, fasting time and level of self-reported physical activity, had
significantly different body weight, waist circumference, waist-to-
hip-ratio, body mass index (BMI), mean arterial blood pressure,
resting heart rate, non-fasting glucose, triglycerides, micro C-
reactive protein (CRP), alanine aminotransferase (ALAT) and
gamma glutamyl transferase (Gamma-GT), but not total choles-
terol (Table 1). Data from questionnaires revealed that the own-
reported health status was significantly better in the high VO2max-
group compared to the low VO2max-group (Table 2). Dietary
questionnaires indicated only differences in fruit and berry intake
between the two groups (Table 2).
MR spectra indicated differences between the metabolic profiles
of the high and low VO2max-groups (Figure 1A). Exploration of the
corresponding loading profiles (Figure 1B) and MR spectra
(Figure 2) showed that low VO2max-subjects had higher levels of
lipid methylene (-CH2-) protons (peak at 1.3 ppm), indicating
decreased amounts of unsaturated fatty acids in serum from the
low VO2max-subjects. The low VO2max-subjects also had lower
levels of phosphatidylcholine (PtdCho) (-N(CH3)3
+, peak at
3.24 ppm) (Figure 2). A permutation test showed that the
differences in the metabolic profiles between high and low
VO2max-subjects were highly significant (p,0.001). The model
created by the MR metabolomics analysis could predict whether a
subject has a low or high VO2max with a sensitivity and specificity
of 63% and 65%, respectively.
A subsequent colorimetric analysis to further study the
differences in choline-containing compounds showed that the
levels of free choline were significantly higher in the low VO2max-
group compared to the high VO2max-group (14.5761.55 vs.
10.1360.91 mM, p = 0.017). The serum choline levels seemed to
correlate with the serum triglycerides levels (high VO2max-group,
r = 0.50, p,0.005 and low VO2max-group, r = 0.74, p,0.0001).
There was no correlation between free choline levels and fasting
status.
Replicate 1H MR spectra of serum with assignments of the main
metabolites are illustrated in Figure 3. The score plot (Figure 3)
clearly displays a larger inter subject variance compared to intra
subject variance, which indicates excellent reproducibility. To
further assess the agreement between metabolite levels obtained by
laboratory assays and MR, the glucose concentration obtained by
standard methodology were correlated with the MR signal
intensities (relative quantification by peak integration 3.90–
3.94 ppm) for glucose. The data showed strong correlations
(R2 = 0.83).
Discussion
The main findings of this study were that the subjects with low
VO2max had increased serum levels of free choline and decreased
serum levels of phosphatidylcholine (PtdCho) compared to subjects
with high VO2max. In human cells, the majority of choline is taken
up by the cells and conversed into PtdCho. Since the ratio of
choline/PtdCho is switched between the subjects with high and
low VO2max, there might be difference in one of the enzymes of
the plasma membrane, phospholipase D (PLD). PLD catalyzes the
hydrolysis of PtdCho to phosphatic acid (PA), releasing soluble
choline. High PLD activity and increased level of PA has
previously been associated with oxidative stress, hypoxia, inflam-
mation, atherosclerosis and hypertension (reviewed in [12]). In the
Table 1. A statistical overview of the participants in this study.
Variable Low VO2max-group High VO2max-group p-value
n mean CI n mean CI
Age 108 49.5 48.4–50.6 110 49.5 48.4–50.6 –
VO2max (mL?kg
20.75?min21) 108 93.9 90.9–96.9 110 138.0 133.4–142.7 –
Physical activity index score 108 3.7 3.4–4.0 110 3.7 3.4–4.0 –
Waist (cm) 108 93.6 91.5–95.7 110 86.3 84.6–88.1 0.0004**
Hip (cm) 108 103.8 102.4–105.3 110 100.1 99.2–101.1 0.0004**
Arm circumference (cm) 108 30.3 29.7–30.9 110 28.7 28.3–29.2 0.0004**
Weight (kg) 108 80.7 77.9–83.5 110 73.5 71.4–75.6 0.0004**
Waist-to-hip-ratio 108 0.90 0.88–0.91 110 0.86 0.85–0.87 0.0004**
BMI 108 27.5 26.8–28.3 110 24.8 24.3–25.2 0.0004**
Heart rate at rest 103 62.3 60.2–64.4 102 55.8 53.9–57.7 0.0004**
Systolic blood pressure (mmhg) 108 128.5 125.6–131.5 110 124.9 122.2–127.5 0.070
Diastolic blood pressure (mmhg) 108 75.2 73.2–77.1 110 72.5 70.7–74.3 0.051
Mean arterial pressure 108 93.0 90.9–95.1 110 90.0 88.0–91.9 0.038*
Alanine aminotransferase (U/L) 13 40.3 20.7–59.9 25 25.3 21.3–29.4 0.038*
Gamma glutamyl transferase (U/L) 13 52.8 20.2–85.4 25 27.8 18.8–36.8 0.049*
Non-fasting glucose (mmol/L) 103 5.7 5.4–6.0 104 5.2 5.0–5.3 0.004**
Cholesterol (mmol/L) 103 5.6 5.4–5.7 104 5.5 5.3–5.6 0.447
HDL-cholesterol (mmol/L) 103 1.4 1.3–1.4 104 1.5 1.4–1–5 0.074
Triglycerides (mmol/L) 77 1.7 1.5–1.9 90 1.3 1.1–1.4 0.002**
Serum micro C-reactive protein (mg/L) 76 2.2 1.3–3.2 90 1.2 0.9–1.6 0.040*
VO2max: Maximal oxygen uptake, CI: Confidence Interval, BMI: Body Mass Index, HDL: High Density Lipoprotein. P-values below 0.05 are flagged. **p,0.005, *p,0.05.
doi:10.1371/journal.pone.0042330.t001
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heart, high PLD activity and increased level of PA are suggested to
be involved in the signaling cascade promoting pathological
cardiac hypertrophy [13]. If our assumptions are correct, even
healthy individuals with a low aerobic fitness may have a high
PLD activity, which may link low aerobic fitness to the future
development of CVD.
Other explanation for the high levels of serum choline in the low
VO2max-group may be release of choline from damaged organs,
impaired tissue uptake or choline-rich diet [14,15]. In patients
with severe repetitive arrhythmias and hemodynamic compromis-
es, choline has been shown to leak from ischemic tissues into the
blood stream [16–18]. However, since the participants in the
current study were healthy it seems unlikely that the increased
levels of choline arise from myocardial release. Regarding diet, a
previous study indicated a weak inverse association between serum
choline and time since last meal [19]. In the current study the
groups were matched on fasting status, and no important
differences were found in diet. Thus, the observed differences in
free choline levels are not likely to be caused by differences in food
intake.
High serum levels of free choline have previously been
associated with an increased prevalence of the metabolic syndrome
(a cluster of risk factors of CVD) [19]. Since the subjects in the low
VO2max-group not fulfilled the criteria for the metabolic
syndrome, our results may indicate that serum levels of choline
may have prognostic value for future CVD even among healthy
subjects. Free choline levels should therefore be assessed in a large
healthy cohort to prospectively study the prognostic value for later
cardiovascular events. Furthermore, elevated levels of choline have
recently been recognized as a novel biomarker for early risk
stratification in patients with suspected acute coronary syndrome
[16–18]. To our knowledge, no previous study has reported
associations between VO2max level and free choline.
In addition to the differences in choline-containing compounds,
the MR spectra also indicated that the subjects with low VO2max
had decreased amounts of unsaturated fatty acids. Decreased
serum levels of unsaturated fatty acids have previously been
associated with increased risk of CVD [20].
The differences in weight, waist circumference, waist-to-hip-
ratio, BMI, mean arterial blood pressure, resting heart rate, non-
Table 2. Data from questionnaires.
Variable Low VO2max-group High VO2max-group p-value
n mean CI n mean CI
Own reported health status (scale 1–4) 104 3.0 2.8–3.1 107 3.3 3.2–3.4 0.001**
Vegetables intake (scale 1–5) 108 3.5 3.3–3.6 110 3.6 3.4–3.7 0.293
Fruit and berry intake (scale 1–5) 108 3.4 3.2–3.7 110 3.8 3.6–4.0 0.029*
Sausage and hamburger intake (scale 1–5) 108 1.3 1.3–1.5 108 1.2 1.2–1.4 0.102
High-fat fish intake (scale 1–5) 108 1.5 1.5–1.8 108 1.5 1.4–1.7 0.730
Food intake: 1 = 0–3 times a month, 2 = 1–3 times a week, 3 = 4–6 times a week, 4 = Once a day, 5 = 2 times or more each day. VO2max: Maximal oxygen uptake, CI:
Confidence interval. P-values below 0.05 are flagged. **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0042330.t002
Figure 1. Principal Component Analysis (PCA) of the serum 1H MR spectra. (A) In the score plot, high VO2max subjects are shown in green
(higher density in upper left part) and low VO2max subjects are shown in red. (B) The loadings plot visualizes the differences in metabolites between
the two groups. The signals originating from within the core of the serum lipoprotein particles (-CH3 at 0.86 ppm, -CH2- at 1.3 ppm) and choline-
containing compounds (-N (CH3)3
+, at 3.24 ppm) are mainly responsible for the clustering. VO2max: Maximal oxygen uptake.
doi:10.1371/journal.pone.0042330.g001
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Figure 2. Visualization of the metabolic differences in MR spectra. The green spectrum is from a high VO2max subject (green dots in PCA
score plot) and the red spectrum is from the low VO2max (red dots in PCA score plot). VO2max: Maximal oxygen uptake.
doi:10.1371/journal.pone.0042330.g002
Figure 3. Representative 1H NOESYGPPR 1D spectra with assignments of the main metabolites. The spectra in red (and black) consist of
5 spectra (superimposing) from two of the subjects. The reproducibility was evaluated by PCA and the score plot shows the spectra from all 6
subjects, clearly depicting larger inter subject variance compared to intra subject variance. NACl and NAC2 refer to composite acetyl signals from a1-
acid glycoprotein. PCA: Principal Component Analysis.
doi:10.1371/journal.pone.0042330.g003
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fasting glucose, triglycerides, micro-CRP between the high and
low VO2max-groups are supported by previous findings [21–23].
In addition, the increased levels of circulating liver enzymes
(ALAT and Gamma-GT) in the low VO2max-group may reflect
more liver fat and increased insulin resistance [24]. Previous
results from a study of rats with genetically low aerobic capacity
indicate that low VO2max impairs the hepatic oxidative capacity
and therefore contributes to increased amounts of liver fat [25].
Elevated levels of Gamma-GT, even within the normal range,
have previously been associated with the presence of CVD risk
factors, metabolic syndrome, and type 2-diabetes [26,27].
Ideally, obtaining blood samples after overnight fasting would
be preferable due to the elimination of chylomicrones from the
circulation further enabling a more detailed overview of lipids and
lipoprotein sub-classes [28]. However, fasting for several hours is
neither easy to accomplish in a population-based large-scale study,
nor preferable when performing a VO2max-test. In addition to a
possible influence on the lipid metabolites in the MR spectra, it is
also possible that the lack of fasting may have interfered with the
results on glucose and total cholesterol levels. In this study there
was no difference in total cholesterol levels between the high and
low VO2max-group. Previous studies have reported inverse
correlation between VO2max and total cholesterol [29,30].
In conclusion, low VO2max is associated with elevated levels of
free choline and decreased levels of phosphatidylcholine, even in a
cohort of healthy individuals. The precise reason for the shift in
the choline/phosphatidylcholine ratio between subjects in the high
versus the low VO2max-group is unclear, but might be associated
with phospholipase activity, or differences in cardiac or hepatic
release. Further studies should be conducted on free choline and
phosphatidylcholine to validate their potential as early risk-
markers of CVD and predictors of VO2max.
Materials and Methods
Study Participants
The third wave of the Nord-Trøndelag Health Study (HUNT3)
in Norway was carried out between 2006 and 2008 and the results
reported in the present publication stems from this part of the
large HUNT study. Among 50,821 participants in HUNT3, 4631
healthy, adult subjects attended a sub-study designed to measure
VO2max, called the Fitness Study [31]. Participants in the Fitness
Study reported to be free from heart- or lung-disease (details
previously described [31]). From the Fitness Study-population, 220
individuals between 40 and 59 years were selected pair-wise with
one having low and the other high VO2max (selected from top or
bottom 15 subjects within each age-year), but otherwise same
gender, equal age in years, same physical activity index score
(within 15% difference) and equal time since last meal. Subjects
were ranged according to VO2max reported as mL?kg
20.75?min21,
and maximum five pairs of subjects were matched from each age-
year. Two subjects did not provide a blood sample, and the study
thus included 218 subjects (45 males and 63 females in the low
VO2max-group, and 46 males and 64 females in the high VO2max-
group).
The study was approved by the Regional Committee for
Medical Research Ethics, the Norwegian Data Inspectorate, and
by the National Directorate of Health. The study is in conformity
with Norwegian laws and the Helsinki declaration, and all
participants signed a document of consent.
Clinical Measurements
Weight and height were measured on a combined scale (Model
DS-102, Arctic Heating AS, Nøtterøy, Norway), and BMI was
calculated as weight divided by height squared (kg m22). Blood
pressure and resting heart rate were both measured while sitting
(Critikon Dinamap 845XT, GE Medical Systems, Little Chalfont,
Buckinghamshire, United Kingdom) and followed established
guidelines [32].
An individualized protocol was applied to measure VO2max
treadmill running to exhaustion [33]. The VO2max-test was
performed using a ramp protocol where the speed was constant
and the incline was increased with 2% every second minute until
VO2max was reached. Oxygen uptake kinetics were measured
directly by a portable mixing chamber gas-analyzer (Cortex
MetaMax II, Cortex, Leipzig, Germany) with the participants
wearing a tight face mask (Hans Rudolph, Kansas City, USA)
connected to the MetaMax II. The system has previously been
found valid [34]. Heart rate was measured by radio telemetry
(Polar S610i, Polar Electro Oy, Kempele, Finland). From the
warm-up pace, the load was regularly increased when oxygen
uptake kinetics flattened. Along with a respiratory quotient of 1.05
or higher, a maximal test was considered achieved when the
oxygen uptake did not increase more than 2 mL?kg21?min21 at
the highest effort or before the participant disembarked the
treadmill [35]. VO2max was measured as litres of oxygen per
minute (L?min21), and subsequently calculated as VO2max relative
to body mass (mL?kg21?min21) and VO2max scaled
(mL?kg20.75?min21).
Blood Analysis
All clinical-chemical analyses were performed on fresh venous
non-fasting blood samples at Levanger Hospital, Norway. Non-
fasting glucose (mmol/L) was analysed by Hexokinase/G-G-PDH
methodology (reagent kit 3L82-20/3L82-40 Glucose, Abbot,
Clinical Chemistry, USA). HDL-cholesterol (mmol/L) was ana-
lysed by Accelerator selective detergent methodology (reagent kit
3K33-20 Ultra HDL, Abbot, Clinical Chemistry, USA). Triglyc-
erides (mmol/L) were analysed by Glycerol Phosphate Oxidase
methodology (reagent kit; 7D74 Triglyceride, Abbot, Clinical
Chemistry, USA). Creatinine (mg/dl) was analysed by Alkaline
Picrate methodology (reagent kit; 7D65-20 Creatinine, Abbot,
Clinical Chemistry, USA). Alanine aminotransferase (U/L) was
analysed by NADH (with P-59-P) methodology (reagent kit; 8D36-
30 Alanine aminotransferase activated, Abbot, Clinical Chemistry,
USA). Measurements below the instrument range were recorded
as 9 U/L. Gamma glutamyl transferase (Gamma-GT) (U/L) was
analysed by L-Gamma-glytamyl-3-carboxy-4-nitroanilide sub-
strate methodology (reagent kit; 7D65-20 Gamma-glutamyl
transferase, Abbot, Clinical Chemistry, USA). Measurements
below and above instrument range were recorded as 3 U/L and
1544 U/L, respectively. Serum micro C-reactive protein (mg/L)
was analysed by Areoset CRP Vario kit (Abbot, Clinical
Chemistry, USA). Measurements below instrument range are
recorded as 0.
Questionnaire-based Information
Physical activity was registered based on the responses to a self-
administered questionnaire applied (http://www.ntnu.edu/hunt/
data/que) [36]. The questionnaires included three questions:
Question 1: ‘‘How frequently do you exercise?’’, with the response
options ‘‘Never’’ (0), ‘‘Less than once a week’’ (0), ‘‘Once a week’’
(1), ‘‘2–3 times per week’’ (2.5) and ‘‘Almost every day’’ (5).
Question 2: ‘‘If you exercise as frequently as once or more times a
week: How hard do you push yourself?’’ with the response options:
‘‘I take it easy without breaking a sweat or losing my breath’’ (1), ‘‘I
push myself so hard that I lose my breath and break into sweat’’ (2)
and ‘‘I push myself to near exhaustion’’ (3). Question 3: ‘‘How
Metabolites and Fitness in Healthy Subjects
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long does each session last?’’, with the response options: ‘‘Less than
15 minutes’’ (0.1), ‘‘16–30 minutes’’ (0.38), ‘‘30 minutes to
1 hour’’ (0.75) and ‘‘More than 1 hour’’ (1.0). Each participant’s
response to the above mentioned three questions (i.e. numbers in
brackets) were multiplied to calculate a physical activity index
score [36]. As the second and third question only addressed people
who exercised at least once a week, both ‘‘Never’’ and ‘‘Less than
once a week’’ yielded an index score of zero. Participants with a
zero score were categorized as inactive.
Dietary habits were self-reported in a questionnaire. For ‘‘Fruit
and berries’’, ‘‘Vegetables’’, ‘‘Sausages/hamburgers’’ and ‘‘High-
fat fish’’ the possible response-options were ‘‘0–3 times a month’’
(1), ‘‘1–3 times a week’’ (2), ‘‘4–6 times a week’’ (3), ‘‘once a day’’
(4), and ‘‘twice or more a day’’ (5). Health-status was also self-
reported and the options were ‘‘bad’’ (1), ‘‘not quite good’’ (2),
‘‘good’’ (3), or ‘‘very good’’ (4). The mean values were calculated
from the answers from all the participants in each group (i.e.
numbers in brackets).
Metabolic Profiling
Venous non-fasting blood samples were collected in serum-
tubes with no additives. The blood was centrifuged at 3000 rpm
for 10 minutes approximately 1 hour after sample collection. The
serum samples were stored at 280uC in the biobank until being
used for metabolic profiling. The serum samples were slowly
thawed at 4uC. Aliquots of 150 mL were mixed with equal
amounts of buffer solution (Na2HPO4 67H2O (0.075M), 4%
NaN3 in H2O (5ml, mass % of NaN3 versus mass % of H2O), TSP
(3-(trimethyl-silyl) propionic acid-d4, 0.4g), D2O (100 mL), pH
adjusted to 7.4 with 1M HCl (1M NaOH), filled up to 500 mL
with H2O) and transferred to high-quality 3 mm MR tubes. The
ratio between H2O and D2O was 90:10 in all samples. In order to
assess the reproducibility of sample preparation and spectral
acquisition, our daily protocol included a set of five samples
individually prepared from a single healthy individual every day.
MR Experiments
The MR spectra were acquired using a Bruker Avance II
(Bruker Biospin, Rheinstetten, Germany) with digital receiver unit
(DRU) operating at 600 MHz for proton (1H). The probe was a
TCI 1H-13C/15N/D with z-gradient and automated tuning and
matching unit. All spectra were recorded in an automatic fashion
using a BACS-60 sample changer and the ICON-NMR software
(Bruker Biospin). Proton spectra were obtained at a constant
temperature of 310 K using a modified Carr-Purcell-Meiboom-
Gill (CPMG) pulse sequence with presaturation during the
relaxation delay (Bruker: cpmgpr1d) to achieve water suppression
and to facilitate the detection of low molecular weight species by
avoiding the large overlapped signals derived from proteins and
large molecules. The spectra were collected with 64 scans and 4
dummy scans. The acquisition time is set to 3.067 sec, measuring
the FID via collection of 36864 complex data point resulting in a
sweep width of 20.0363 ppm. A relaxation delay of 4 seconds was
used, during which a presaturation of 25 Hz was applied. Effective
echo time was 80ms and data acquisition starts at maximum of last
echo. An exponential apodization of 1Hz was applied prior to
Fourier transform. Measurement and processing was done in full
automation using Bruker standard automation programs con-
trolled by ICON-NMR (along with TopSpin v2.1 patchlevel 6).
Chemical shift was calibrated to the middle of the alanine peaks at
1.50 ppm. The reproducibility spectra were acquired using
nuclear Overhauser effect spectroscopy (NOESY, Bruker: noe-
sygppr1d) with the same parameters as CPMG with the exception
of 32 scans. The assignments of chemical shifts were done on the
basis of previously published data [37].
Data Processing and Multivariate Analysis
Data analysis was performed with MATLAB (Version 7.9.0;
The Math Works, Natick, MA, USA). The spectra were divided
into 850 segments, each 0.01 ppm wide for a spectral window
ranging from 0.5 to 9.0 ppm to reduce minor chemical shift
alterations [38]. The segments between 4.5–5.0 ppm were
excluded to remove variation in water suppression efficiency.
Spectra were finally normalized by setting the total spectral area to
a constant value ( = 1) for all spectra to minimize possible
differences in serum concentration between the samples.
Unsupervised principal component analysis (PCA) and super-
vised partial least squares discriminant analysis (PLS-DA) were
performed using PLS_Toolbox v5.8.3 (Eigenvector Research,
Manson, WA, USA). PCA reduces the dimensionality of the data
and summarizes the structure of the multiple MR spectra
visualized in score plots and loading profiles. The variance
structure of the data is explained through linear combinations of
the variables called principal components (PCs). The first PCs will
be in the direction explaining most of the variance in the data set.
In the score plot of the PCs, samples with a similar metabolic
profile will cluster, while the corresponding loading profile displays
the importance of each variable within the PC. PLS-DA is a
supervised classification method which uses the class information
to detect variables generating maximum separation between the
classes (high and low aerobic capacity). All statistical models were
cross-validated with a single 10-fold Venetian blind cross
validation; in each run 10% of the data were left out of the
training and used to test the model. The optimal model contains
the number of latent variables yielding the lowest percentage of
misclassification. A permutation test was performed (10000
permutations) to evaluate the significance of the difference
between the classes [39].
To evaluate the reproducibility of the sample preparation and
metabolomics analyses, PCA of the replicate spectra from single
subjects (in total 30 sample preparations from 6 subjects) were
performed for comparison of the inter versus intra subject
variance.
Colorimetric Analysis of Free Choline
In a sub-cohort of 39 participants (20 women and 19 men) from
the low VO2max-group and 38 participants (21 women and 17
men) from the high VO2max-group, the level of free choline was
measured in serum. The groups were matched on fasting status,
age and physical activity index score. The serum was analysed
with the Choline/Acetylcholine Quantification Kit according to
the manufacturer’s instructions (Abnova, Taipei City, Taiwan).
Statistical Analyses
PASW Statistics 17.0 (IBM, New York, USA) was used for
traditional statistical analyses. All statistical tests were two-sided,
and p-values below 0.05 were considered statistical significant.
Kolmogorov-Smirnov test was used to test for normality. One-
Way ANOVA was used for comparing variables between the high
and the low VO2max-groups, and Kruskal-Wallis test was used in
non-parametric analyses. Results are given in mean 6 SE.
Pearson’s correlation was used to study associations between
normally distributed variables, and Spearman’s correlation was
used in non-parametric analyses. The correlation analyses were
performed separately for the high and low VO2max-group.
Metabolites and Fitness in Healthy Subjects
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